AI-based Clinical Trial Solutions for Patient Matching Top Companies Study - Unlearn.AI, Inc., Antidote Technologies, Inc., Deep6.ai, Mendel.ai, Aris Global.

"AI-based Clinical Trial Solutions for Patient Matching Market" in terms of revenue was estimated to be worth $369.12 Mn in 2023 and is poised to reach USD 6205.4 Million by the year 2034, growing at a CAGR of 29.6% from 2025 to 2034 according to a new report by InsightAce Analytic.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1430

Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global AI-based Clinical Trial Solutions for Patient Matching market are:
• Growing awareness of the benefits of AI-based clinical trials
• Demand for personalized medicine
• Growing demand for AI-powered technologies

The following are the primary obstacles to the AI-based Clinical Trial Solutions for Patient Matching market's expansion:
• Time-consuming, expensive

Future expansion opportunities for the global AI-based Clinical Trial Solutions for Patient Matching market include:
• Rising healthcare expenditures by market players
• Official training to stakeholders about AI-based clinical trial solution

Market Analysis:
The rising prevalence of chronic diseases, coupled with an increasing demand for advanced therapeutics, is a key factor driving market growth. Artificial intelligence is playing a pivotal role in optimizing various aspects of clinical trials, including patient selection and recruitment, trial design, site selection, and ongoing patient monitoring. Additionally, AI-powered patient matching solutions can efficiently identify individuals who meet specific criteria or possess the necessary biomarkers for particular trials, thereby accelerating the development and delivery of targeted treatment options.

List of Prominent Players in the AI-based Clinical Trial Solutions for Patient Matching Market:
• Al, Inc.,
• Antidote Technologies, Inc.,
• Aris Global,
• Deep Lens Al,
• AmerisourceBergen Corporation,
• Konaks,
• Microsoft Corporation,
• GNS Healthcare

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Recent Developments:
• In September 2022, the Bridge2AI program, which will have participants from different groups and focus on providing various tools, resources, and data for developing an AI strategy, was introduced by The NIH.
• In February 2022, Qureight received a seed investment of USD 1.50 million for its AI-based platform, which helped in reducing the cost of medication by speeding up clinical studies and reducing their duration.

AI-based Clinical Trial Solutions for Patient Matching Market Dynamics:
Market Drivers: Rising Adoption of AI-Driven Technologies
The growing adoption of AI-powered technologies in clinical research is being significantly supported by initiatives from both the public and private sectors. This surge in support is contributing to the substantial expansion of the AI-based clinical trial solutions market, particularly in patient matching applications. Pharmaceutical and biotechnology companies are increasingly integrating these platforms to enhance the efficiency of their research efforts. These advanced technologies facilitate improved patient identification, recruitment, engagement, and real-time monitoring, thereby streamlining the clinical trial process.

Challenges: High Costs and Time-Intensive Processes
Conventional research and development methodologies in the pharmaceutical and biotechnology sectors are characterized by lengthy timelines and substantial financial investment. These high development costs pose a significant challenge for industry players. To address these issues, companies are increasingly turning to artificial intelligence to enhance data accuracy, reduce operational costs, and shorten clinical trial durations. However, the substantial initial investment and implementation complexity continue to act as constraints on the broader adoption and growth of AI-based solutions in this field.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1430

North America Is Expected To Grow With the Highest CAGR during the Forecast Period
The North American market for AI-based clinical trial solutions for patient matching is expected to capture a significant revenue share and experience rapid growth in the near future. This expansion is primarily driven by the increasing adoption of AI technologies and a growing awareness of their benefits. Key factors contributing to market growth include the availability of a large patient population, cost-effective access to skilled labor, and competitive hiring rates. Additionally, the rise of numerous startups in the region, fueled by the increasing demand for these solutions, is anticipated to create new opportunities for the industry.

Segmentation of AI-based Clinical Trial Solutions for Patient Matching Market-
By Therapeutic Application-
• Oncology
• Cardiovascular Disease
• Neurological Diseases or Conditions
• Metabolic Diseases
• Infectious Diseases
• Others
By End Use-
• Pharmaceutical Companies
• Academia
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/global-ai-based-clinical-trial-solutions-for-patient-matching-market-/1430

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.